Yahoo, when looked at in a certain way, is worth approximately -$8 billion.

Posted by & filed under Company Analysis, Financial analysis, Growth & Valuation, Industry Analysis.

Description: The minus sign above isn’t a typo. Source: Bloomberg.com – video report Date: April 28, 2016 Link: http://www.bloomberg.com/features/2016-yahoo/ Questions for Discussions: Summarize Yahoo!’s key financials presented in the report. What do you think the value of the firm is to investors?

Opinion: This holds the key to timing Apple share purchases

Posted by & filed under Company Analysis, Financial analysis.

Description: Pay close attention to analysts’ revisions, says Mark Hulbert Source: MarketWatch.com Date: Apr 29, 2016 Link: http://www.marketwatch.com/story/this-holds-the-key-to-timing-apple-share-purchases-2016-04-29 Questions for Discussions: What is the key to this investment decision, according to the report? Do you agree with this assessment and advice?

Opinion: Why Under Armour is a better investment than Nike

Posted by & filed under Company Analysis, Financial analysis, Industry Analysis.

Description: Much faster sales growth has driven outsized stock performance at Under Armour Source: MarketWatch.com Date: Apr 22, 2016 Link: http://www.marketwatch.com/story/why-under-armour-is-a-better-investment-than-nike-2016-04-21 Questions for Discussions: What is the basis for suggesting UA is a better investment than Nike? Do you agree with the assessments and recommendation?

Uber says it’s profitable in the US — here’s how much it makes per ride

Posted by & filed under Financial analysis, Industry Analysis.

Description: Uber has been pushing to reach profitability in the US and Canada by the second quarter of 2016, and the company now says it’s made that goal, according to a new report by Bloomberg’s Eric Newcomer. Source: Yahoo.com/BusinessInsider.com Date: Apr 14, 2016 Link: https://finance.yahoo.com/news/uber-says-profitable-us-much-151211910.html Questions for Discussions: What do you think of the financials… Read more »

‘Affordable’ Tesla Model 3 revealed as Elon Musk charges up the crowd

Posted by & filed under Company Analysis, Financial analysis, Growth & Valuation.

Description: More than 135,000 people have already paid $1K to reserve one Source: MarketWatch.com Date: Apr 01, 2016 Link: http://www.marketwatch.com/story/tesla-model-3-elon-musk-charges-up-the-crowd-for-mass-appeal-car-2016-04-01 Questions for Discussions: Do you think the model 3 will catapult Tesla stock value? How should investors interpret the meaning of 135,000 people depositing funds for future delivery of a car?

The Netflix of Fashion: Rent the Runway Streams Wardrobes

Posted by & filed under Financial analysis, Growth & Valuation.

Description: The Netflix of Fashion: Rent the Runway Streams Wardrobes Source: Bloomberg.com – video report Date: Mar 24, 2016 Link: http://bloom.bg/1q4RukG Questions for Discussions: Do you think this business model is sustainable? Explain your thinking? Do you think low barriers to entry present a problem for this firm’s growth? How would you characterize the risk… Read more »

In Yahoo, Another Example of the Buyback Mirage

Posted by & filed under Financial analysis, Growth & Valuation.

Description: It is one of the great investment conundrums of our time: Why do so many stockholders cheer when a company announces that it’s buying back shares? Source: NYTimes.com Date: Mar 25, 2016 Link: http://www.nytimes.com/2016/03/27/business/in-yahoo-another-example-of-the-buyback-mirage.html?ref=business&_r=0 Questions for discussion: What is the buyback mirage warning all about? How should investors weigh firms that choose to take… Read more »

Valeant Pharmaceuticals International Inc creditors prepare to slam company with tougher demands in face of possible default: sources

Posted by & filed under Company Analysis, Financial analysis, Governments & Regulators, Growth & Valuation.

Description: NEW YORK – Creditors of Valeant Pharmaceuticals International, which has been in violation of lender agreements since Wednesday, are beginning to demand new terms that could further pressure the drugmaker’s business model, according to three people familiar with the matter. Source: Reuter.com/FinancialPost.com Date: Mar 21, 2016 Link: http://business.financialpost.com/investing/market-moves/valeant-pharmaceuticals-international-inc-creditors-prepare-to-slam-company-with-tougher-demands-in-face-of-default-sources Questions for Discussions: Do you think… Read more »

Would You Pay 25 Cents to Read an Article? Blendle Certainly Thinks So

Posted by & filed under Company Analysis, Financial analysis, Industry Analysis.

Description: BLENDLE IS A Dutch media startup that lets you pay a few cents for individual news articles online—the much chattered-about micropayments model that’s one of many on a long list of strategies destined to save the business of journalism (or not). And now it’s available in the US. Source: Wired.com Date: Mar 23, 2016… Read more »

After $600 Million Typo, Valeant CEO Is Back on the Hot Seat

Posted by & filed under Company Analysis, Financial analysis, Governments & Regulators, Growth & Valuation.

Description: Michael Pearson and his company, Valeant Pharmaceuticals International Inc., were supposed to calm Wall Street doubters on Tuesday. Instead: chaos. Source: Bloomberg.com – video report Date: Mar 15, 2016 Link: http://www.bloomberg.com/news/articles/2016-03-15/after-a-600-million-typo-valeant-s-ceo-is-back-on-the-hot-seat Questions for Discussions: Summarize the reasons for Valeant’s share value collapse, according to the report. Do you think it has collapsed completely and… Read more »